It appears you don't have support to open PDFs in this web browser. To view this file, Open with your PDF reader
Abstract
Body contouring achieved via subcutaneous adipose tissue reduction has notably advanced over the past century, from suction assisted lipectomy to techniques with reduced degrees of invasiveness including laser, radiofrequency, high frequency focused ultrasound, cryolipolysis, and drug-based injection approaches. These costly techniques have focused on damaging adipocyte cell membranes, hydrolyzing triglycerides (TGs), or inducing apoptosis. Here, we present a simple, low-cost technique, termed electrochemical lipolysis (ECLL). During ECLL, saline is injected into the subcutaneous adipose tissue, followed by insertion of needle electrodes and application of an electrical potential. Electrolysis of saline creates localized pH gradients that drive adipocyte death and saponification of TGs. Using pH mapping, various optical imaging techniques, and biochemical assays, we demonstrate the ability of ECLL to induce acid and base injury, cell death, and the saponification of triglycerides in ex vivo porcine adipose tissue. We define ECLL’s potential role as a minimally-invasive, ultra-low-cost technology for reducing and contouring adipose tissue, and present ECLL as a potential new application of an emerging electrochemical redox based treatment modality.
You have requested "on-the-fly" machine translation of selected content from our databases. This functionality is provided solely for your convenience and is in no way intended to replace human translation. Show full disclaimer
Neither ProQuest nor its licensors make any representations or warranties with respect to the translations. The translations are automatically generated "AS IS" and "AS AVAILABLE" and are not retained in our systems. PROQUEST AND ITS LICENSORS SPECIFICALLY DISCLAIM ANY AND ALL EXPRESS OR IMPLIED WARRANTIES, INCLUDING WITHOUT LIMITATION, ANY WARRANTIES FOR AVAILABILITY, ACCURACY, TIMELINESS, COMPLETENESS, NON-INFRINGMENT, MERCHANTABILITY OR FITNESS FOR A PARTICULAR PURPOSE. Your use of the translations is subject to all use restrictions contained in your Electronic Products License Agreement and by using the translation functionality you agree to forgo any and all claims against ProQuest or its licensors for your use of the translation functionality and any output derived there from. Hide full disclaimer
Details


1 Beckman Laser Institute and Medical Clinic, University of California - Irvine, Irvine, USA (GRID:grid.266093.8) (ISNI:0000 0001 0668 7243)
2 Occidental College, Department of Chemistry, Los Angeles, USA (GRID:grid.217156.6) (ISNI:0000 0004 1936 8534)
3 Beckman Laser Institute and Medical Clinic, University of California - Irvine, Irvine, USA (GRID:grid.266093.8) (ISNI:0000 0001 0668 7243); Beckman Laser Institute, University of California - Irvine, Department of Biomedical Engineering, Irvine, USA (GRID:grid.266093.8) (ISNI:0000 0001 0668 7243)
4 Dankook University College of Medicine, Beckman Laser Institute-Korea, Cheonan-si, Chungnam, Republic of Korea (GRID:grid.411982.7) (ISNI:0000 0001 0705 4288)
5 Dankook University College of Medicine, Department of Otorhinolaryngology, Cheonan-siChungnam, Republic of Korea (GRID:grid.411982.7) (ISNI:0000 0001 0705 4288)
6 Dankook University College of Medicine, Department of Biomedical Engineering, Cheonan-siChungnam, Republic of Korea (GRID:grid.411982.7) (ISNI:0000 0001 0705 4288)
7 Beckman Laser Institute and Medical Clinic, University of California - Irvine, Irvine, USA (GRID:grid.266093.8) (ISNI:0000 0001 0668 7243); Beckman Laser Institute, University of California - Irvine, Department of Biomedical Engineering, Irvine, USA (GRID:grid.266093.8) (ISNI:0000 0001 0668 7243); University of California - Irvine, Department of Otolaryngology - Head and Neck Surgery, School of Medicine, Orange, USA (GRID:grid.266093.8) (ISNI:0000 0001 0668 7243)